{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:55:49Z","timestamp":1790931349555,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00259-026-08046-3","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:36:33Z","timestamp":1782887793000},"page":"6909-6919","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Whole-brain metabolic activity on pretreatment [18\u00a0F]FDG PET\/CT provides prognostic information beyond metabolic tumour burden in patients with breast cancer"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1680-4973","authenticated-orcid":false,"given":"Mehmet Tar\u0131k","family":"Tato\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8738-6454","authenticated-orcid":false,"given":"Burak","family":"Can\u0131tez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-261X","authenticated-orcid":false,"given":"Hatice","family":"Uslu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-9092","authenticated-orcid":false,"given":"Ebru","family":"\u0130bi\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7365-3649","authenticated-orcid":false,"given":"Ferda Yerdelen","family":"Tato\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"8046_CR1","doi-asserted-by":"publisher","first-page":"e0225959","DOI":"10.1371\/journal.pone.0225959","volume":"14","author":"W Wen","year":"2019","unstructured":"Wen W, Xuan D, Hu Y, Li X, Liu L, Xu D. Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography\/computed tomography in patients with breast cancer: A systematic review and meta-analysis. PLoS ONE. 2019;14:e0225959. https:\/\/doi.org\/10.1371\/journal.pone.0225959.","journal-title":"PLoS ONE"},{"key":"8046_CR2","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2214\/ajr.14.13906","volume":"205","author":"SH Son","year":"2015","unstructured":"Son SH, Lee SW, Jeong SY, et al. Whole-body metabolic tumor volume, as determined by (18)F-FDG PET\/CT, as a prognostic factor of outcome for patients with breast cancer who have distant metastasis. AJR Am J Roentgenol. 2015;205:878\u201385. https:\/\/doi.org\/10.2214\/ajr.14.13906.","journal-title":"AJR Am J Roentgenol"},{"key":"8046_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.18632\/oncotarget.27851","volume":"12","author":"K Kitajima","year":"2021","unstructured":"Kitajima K, Miyoshi Y, Sekine T, et al. Harmonized pretreatment quantitative volume-based FDG-PET\/CT parameters for prognosis of stage I-III breast cancer: Multicenter study. Oncotarget. 2021;12:95\u2013105. https:\/\/doi.org\/10.18632\/oncotarget.27851.","journal-title":"Oncotarget"},{"key":"8046_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13058-016-0793-2","volume":"19","author":"D Groheux","year":"2017","unstructured":"Groheux D, Martineau A, Teixeira L, et al. 18FDG-PET\/CT for predicting the outcome in ER+\/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis. Breast Cancer Res. 2017;19:3. https:\/\/doi.org\/10.1186\/s13058-016-0793-2.","journal-title":"Breast Cancer Res"},{"key":"8046_CR5","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.2147\/ijgm.s293998","volume":"14","author":"Y Li","year":"2021","unstructured":"Li Y, Liu C, Wang B, et al. Prediction of pretreatment 18F-FDG-PET\/CT parameters on the outcome of first-line therapy in patients with metastatic breast cancer. Int J Gen Med. 2021;14:1797\u2013809. https:\/\/doi.org\/10.2147\/ijgm.s293998.","journal-title":"Int J Gen Med"},{"key":"8046_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10549-022-06852-5","volume":"198","author":"S Han","year":"2023","unstructured":"Han S, Lee SB, Gong G, et al. Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in patients with T2N1 hormone receptor-positive, ERBB2-negative breast cancer who underwent adjuvant chemotherapy. Breast Cancer Res Treat. 2023;198:207\u201315. https:\/\/doi.org\/10.1007\/s10549-022-06852-5.","journal-title":"Breast Cancer Res Treat"},{"key":"8046_CR7","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1007\/s00259-021-05322-2","volume":"48","author":"RD Seban","year":"2021","unstructured":"Seban RD, Rouzier R, Latouche A, et al. Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET\/CT as independent prognostic biomarkers of recurrence in resected breast cancer. Eur J Nucl Med Mol Imaging. 2021;48:3560\u201370. https:\/\/doi.org\/10.1007\/s00259-021-05322-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8046_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/bjr\/tqad015","volume":"97","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li Y, Jiang H, Zuo C, Xu W. Elevated splenic 18F-fluorodeoxyglucose positron emission tomography\/computed tomography activity is associated with 5-year risk of recurrence in non-metastatic invasive ductal carcinoma of the breast. Br J Radiol. 2024;97:237\u201348. https:\/\/doi.org\/10.1093\/bjr\/tqad015.","journal-title":"Br J Radiol"},{"key":"8046_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13550-020-00660-y","volume":"10","author":"JW Lee","year":"2020","unstructured":"Lee JW, Kim SY, Han SW, et al. [18F]FDG uptake of bone marrow on PET\/CT for predicting distant recurrence in breast cancer patients after surgical resection. EJNMMI Res. 2020;10:72. https:\/\/doi.org\/10.1186\/s13550-020-00660-y.","journal-title":"EJNMMI Res"},{"key":"8046_CR10","doi-asserted-by":"publisher","first-page":"21109","DOI":"10.1038\/s41598-022-25540-4","volume":"12","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Kim D, Bae SJ, et al. 18F-FDG uptake of visceral adipose tissue on preoperative PET\/CT as a predictive marker for breast cancer recurrence. Sci Rep. 2022;12:21109. https:\/\/doi.org\/10.1038\/s41598-022-25540-4.","journal-title":"Sci Rep"},{"key":"8046_CR11","doi-asserted-by":"publisher","first-page":"570208","DOI":"10.3389\/fonc.2021.570208","volume":"11","author":"W Li","year":"2021","unstructured":"Li W, Ma G, Deng Y, et al. Systemic immune-inflammation index is a prognostic factor for breast cancer patients after curative resection. Front Oncol. 2021;11:570208. https:\/\/doi.org\/10.3389\/fonc.2021.570208.","journal-title":"Front Oncol"},{"key":"8046_CR12","doi-asserted-by":"publisher","first-page":"830138","DOI":"10.3389\/fonc.2022.830138","volume":"12","author":"F Lin","year":"2022","unstructured":"Lin F, Zhang LP, Xie SY, et al. Pan-immune-inflammation value: a new prognostic index in operative breast cancer. Front Oncol. 2022;12:830138. https:\/\/doi.org\/10.3389\/fonc.2022.830138.","journal-title":"Front Oncol"},{"key":"8046_CR13","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1186\/s12885-022-10218-x","volume":"22","author":"T Xu","year":"2022","unstructured":"Xu T, Zhang SM, Wu HM, et al. Prognostic significance of prognostic nutritional index and systemic immune-inflammation index in patients after curative breast cancer resection: a retrospective cohort study. BMC Cancer. 2022;22:1128. https:\/\/doi.org\/10.1186\/s12885-022-10218-x.","journal-title":"BMC Cancer"},{"key":"8046_CR14","doi-asserted-by":"publisher","first-page":"e0200936","DOI":"10.1371\/journal.pone.0200936","volume":"13","author":"U Cho","year":"2018","unstructured":"Cho U, Park HS, Im SY, et al. Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer. PLoS ONE. 2018;13:e0200936. https:\/\/doi.org\/10.1371\/journal.pone.0200936.","journal-title":"PLoS ONE"},{"key":"8046_CR15","doi-asserted-by":"publisher","first-page":"11463","DOI":"10.2147\/cmar.s277291","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang Y, Huang G, Li Z. Prognostic significance of inflammatory biomarkers in patients with breast cancer skeletal metastases. Cancer Manag Res. 2020;12:11463\u201375. https:\/\/doi.org\/10.2147\/cmar.s277291.","journal-title":"Cancer Manag Res"},{"key":"8046_CR16","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.21873\/anticanres.12809","volume":"38","author":"T Fujii","year":"2018","unstructured":"Fujii T, Yanai K, Tokuda S, et al. Relationship between FDG uptake and neutrophil\/lymphocyte ratio in patients with invasive ductal breast cancer. Anticancer Res. 2018;38:4927\u201331. https:\/\/doi.org\/10.21873\/anticanres.12809.","journal-title":"Anticancer Res"},{"key":"8046_CR17","doi-asserted-by":"publisher","unstructured":"Auriac J, Lemoudda G, Hovhannisyan-Baghdasarian N, et al. Brain metabolic activity measured by [18F]FDG PET\/CT predicts survival in patients with advanced non\u2013small cell lung cancer. J Nucl Med. 2026;67:jnumed.125.271400. https:\/\/doi.org\/10.2967\/jnumed.125.271400.\u00a0","DOI":"10.2967\/jnumed.125.271400"},{"issue":"suppl 1","key":"8046_CR18","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1182\/blood-2024-204976","volume":"144","author":"H Senjo","year":"2024","unstructured":"Senjo H, Harada S, Izumiyama K, et al. Reduced FDG uptake in the brain on baseline 18FDG PET\/CT predicts a worse prognosis of newly diagnosed intravascular large B-cell lymphoma and advanced-stage diffuse large B-cell lymphoma [abstract]. Blood. 2024;144(suppl 1):3096. https:\/\/doi.org\/10.1182\/blood-2024-204976.","journal-title":"Blood"},{"key":"8046_CR19","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.3390\/nu15133042","volume":"15","author":"T Galvez","year":"2023","unstructured":"Galvez T, Berkane I, Th\u00e9zenas S, et al. Identification of 18F-FDG PET\/CT parameters associated with weight loss in patients with esophageal cancer. Nutrients. 2023;15:3042. https:\/\/doi.org\/10.3390\/nu15133042.","journal-title":"Nutrients"},{"key":"8046_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-0043-1766362","volume":"62","author":"A Frille","year":"2023","unstructured":"Frille A, Rullmann M, Hofmann L, et al. Region-specific glucose metabolism in the brain predicts cachexia syndrome in patients with lung cancer. Nuklearmedizin. 2023;62:157. https:\/\/doi.org\/10.1055\/s-0043-1766362.","journal-title":"Nuklearmedizin"},{"key":"8046_CR21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00259-015-3023-8","volume":"42","author":"S Gholami","year":"2015","unstructured":"Gholami S, Segtnan EA, Alavi A. Global and regional brain glucose metabolism decline after systemic chemotherapy. Eur J Nucl Med Mol Imaging. 2015;42:981\u20133. https:\/\/doi.org\/10.1007\/s00259-015-3023-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8046_CR22","doi-asserted-by":"publisher","first-page":"1021615","DOI":"10.3389\/fonc.2022.1021615","volume":"12","author":"G Schroyen","year":"2022","unstructured":"Schroyen G, Schramm G, Van Weehaeghe D, et al. Cerebral glucose changes after chemotherapy and their relation to long-term cognitive complaints and fatigue. Front Oncol. 2022;12:1021615. https:\/\/doi.org\/10.3389\/fonc.2022.1021615.","journal-title":"Front Oncol"},{"key":"8046_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10549-006-9380-z","volume":"103","author":"DH Silverman","year":"2007","unstructured":"Silverman DH, Dy CJ, Castellon SA, et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5\u201310 years after chemotherapy. Breast Cancer Res Treat. 2007;103:303\u201311. https:\/\/doi.org\/10.1007\/s10549-006-9380-z.","journal-title":"Breast Cancer Res Treat"},{"key":"8046_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11682-013-9243-2","volume":"7","author":"KL Pomykala","year":"2013","unstructured":"Pomykala KL, Ganz PA, Bower JE, et al. The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer. Brain Imaging Behav. 2013;7:511\u201323. https:\/\/doi.org\/10.1007\/s11682-013-9243-2.","journal-title":"Brain Imaging Behav"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08046-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:32:19Z","timestamp":1790929939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-08046-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8046"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-08046-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Noninterventional Clinical Research Ethics Committee of Istanbul Goztepe Prof. Dr. Suleyman Yalcin City Hospital (approval no. 2025\/0212; 9 October 2025) and was conducted in accordance with the Declaration of Helsinki. The requirement for additional research-specific informed consent was waived by the Ethics Committee.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was waived; see Ethics approval.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The supplementary images (Fig.\n                      \n                      ) are de-identified maximum intensity projection images that contain no patient-identifying information.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests relevant to the content of this article.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}